<DOC>
	<DOCNO>NCT01651806</DOCNO>
	<brief_summary>Hypotheses : Primary - A weighted dose 20 mg/kg tranexamic acid efficacious single uniform dose 1 gram primary total knee arthroplasty ( TKA ) case . This include great impact decrease blood loss without increase occurrence adverse thromboembolic event patient undergo primary , elective total knee arthroplasty . Secondary - TA decrease blood loss effectively woman men undergoing procedure .</brief_summary>
	<brief_title>Weighted Versus Uniform Dose Tranexamic Acid Patients Undergoing Primary , Knee Arthroplasty</brief_title>
	<detailed_description>Overall Study Design Study design control method : This study design prospective , randomize , double-blinded control clinical trial compare effect single uniform 1 g dose TA single weight 20 mg/kg dose tranexamic acid ( TA ) . Treatment group : The subject randomly assign uniform dose group weight dose group time surgery via open randomly select close envelope . The patient independent reviewer blind dose TA utilized surgery . This information link confidential database later review principal investigator . Treatment allocation : All eligible patient ( i.e. , meet inclusion criterion exclusion criterion ) treat observed per research protocol . All patient maintain right refuse participation receive specific treatment study desire . Trial Population Target population : The target sample size 60 patient uniform weight dose group ( 120 total ) group split evenly male female . There one actively enrol surgeon ( Dr. Brett Levine ) . The goal enroll total 120 subject experience joint pain warrant TKA . The specific diagnosis joint pain direct subject ' assignment eligibility time surgery . All 120 patient enrolled office primary investigator ( Dr. Brett Levine ) . All indication TKA include unless one exclusion criterion meet .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Blood Loss , Surgical</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>1 . Patients must male female race 2 . Ages 1880 year old 3 . Patients must undergo elective , primary knee arthroplasty 4 . Patients must able understand willing cooperate study procedures 5 . Patients must able provide write verbal informed consent 1 . Allergy intolerance study material 2 . History venous thromboembolic event treat lifelong anticoagulation 3 . Patients know congenital thrombophilia 4 . Patients venous thromboembolic event within 12 month precede surgery 5 . History substance abuse dependence within last 6 month 6 . Failure collect require data point study 7 . Those patient indicate knee replacement surgery include , pregnant woman , clear medically procedure patient without significant radiographic evidence degenerative joint disease . 8 . Patient use autologous blood transfusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Blood loss</keyword>
	<keyword>transfusion rate</keyword>
	<keyword>complication</keyword>
</DOC>